References
- Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, et al.
Behçet’s disease—a contemporary review. J Autoimmun. (2009)
32:178–88.
- Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New
insights into the pathogenesis of Behcet’s disease. Autoimmun Rev.
(2012) 11:687–98.
- Duzgun N, Ates ¸ A, Aydintug OT, et al. Characteristics of vascular
involvement in Behcet’s disease. Scand J Rheumatol. 2006;35:65–68.
- Park SJ, Park MJ, Park S, Lee ES, Lee DY. Integrative metabolomics of
plasma and PBMCs identifies distinctive metabolic signatures in
Behçet’s disease. Arthritis Res Ther. 2023 Jan 7;25(1):5.
- Zhang F, Zhang Y, Zhao W, et al. Metabolomics for biomarker discovery
in the diagnosis,prognosis, survival and recurrence of colorectal
cancer: a systematic review. Oncotarget.2017 May 23;8(21):35460-35472.
- International Study Group for Behcet’s Disease. Criteria for diagnosis
of Behcet’s disease. Lancet. 1990;335:1078–108
- Hamuryudan V, Fresko I, Direskeneli H, et al. Evaluation of the
Turkish translation of a disease activity form for Behc¸et’s syndrome.
Rheumatology (Oxford). 1999;38:734–736.
- Kocak E, Nemutlu E, Kir S, Sagiroglu M, Ozkul C. Integrative
proteomics and metabolomics approach to elucidate the antimicrobial
effect of simvastatin on Escherichia coli. Biomed Chromatogr.
2021;35(10):e5180.
- Gonulalan EM, Nemutlu E, Bayazeid O, Kocak E, Yalcin FN, Demirezer LO.
Metabolomics and proteomics profiles of some medicinal plants and
correlation with BDNF activity. Phytomedicine. 2020;74.
- Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med.
1999; 341:1284–1291. PMID: 10528040
- Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular
involvement in Behçet’s syndrome: a retrospective analysis of
associations and the time course. Rheumatology (Oxford). 2014
Nov;53(11):2018-22.
- O’Duffy JD. Vasculitis in Behcet’s disease. Rheum Dis Clin N Am.
1990;16(2): 423–31
- Cakmak OS, Seyahi E, Kantarci F, et al. Venous severity assessment in
Behc¸et’s syndrome. Clin Exp Rheumatol. 2010;28:S-139.
- Guleria, A.; Pratap, A.; Dubey, D.; Rawat, A.; Chaurasia, S.; Sukesh,
E.; Phatak, S.; Ajmani, S.; Kumar, U.; Khetrapal, C.L.; et al. NMR
based serum metabolomics reveals a distinctive signature in patients
with Lupus Nephritis. Sci. Rep. 2016, 6, 35309.
- Van Wietmarschen, H.A.; Dai, W.; van der Kooij, A.J.; Reijmers, T.H.;
Schroen, Y.; Wang, M.; Xu, Z.; Wang, X.; Kong, H.; Xu, G.; et al.
Characterization of rheumatoid arthritis subtypes using symptom
profiles, clinical chemistry and metabolomics measurements. PLoS ONE
2012, 7, e44331
- Wang, W.; Yang, G.J.; Zhang, J.; Chen, C.; Jia, Z.Y.; Li, J.; Xu, W.D.
Plasma, urine and ligament tissue metabolite profiling reveals
potential biomarkers of ankylosing spondylitis using NMR-based
metabolic profiles. Arthritis Res. Ther. 2016, 18, 244.
- Zheng W, Wu X, Goudarzi M, Shi J, Song W, Li C, Liu J, Chen H, Zhang
X, Zeng X, Li HH. Metabolomic alterations associated with Behçet’s
disease. Arthritis Res Ther. 2018 Sep 24;20(1):214.
- Bender, DA. Amino acid metabolism. John Wiley & Sons, Ltd; 2012.
Nitrogen metabolism.; p. 1-65.
- Åslund F, Beckwith J. Bridge over troubled waters: Sensing stress by
disulfide bond formation. Cell. 1999; 96:751–753.
- Isik A, Koca SS, Ustundag B, Selek S. Decreased total antioxidant
response and increased oxidative stress in Behcet’s
disease. Tohoku J Exp Med. 2007;212:133–41.
- Born TL, Blanchard JS. Enzyme-catalyzed acylation of homoserine:
mechanistic characterization of the Escherichia coli metA-encoded
homoserine transsuccinylase. Biochemistry. 1999 Oct
26;38(43):14416-23.
- Kumar, Akhilesh; Bachhawat, Anand K.
(2012). ”Pyroglutamic
acid: throwing light on a lightly studied metabolite” (PDF). Current
Science. 102 (2): 288–297
- Cole, S. P., and Deeley, R. G. (2006) Transport of glutathione and
glutathi-one conjugates by MRP1. Trends Pharmacol. Sci. 27, 438–446
- Morgan, B., Ezerin ̵̧a, D., Amoako, T. N., Riemer, J., Seedorf, M., et
al. (2013)Multiple glutathione disulfide removal pathways mediate
cytosolic redoxhomeostasis. Nat. Chem. Biol. 9, 119–125
- Kromhout, Daan; et al. (1995). ”Dietary Saturated and transFatty Acids
and Cholesterol and 25-Year Mortality from Coronary Heart Disease: The
Seven Countries Study”. Preventive Medicine . 24 (3):
308–315.
- Yücel Ç, Omma A, Sertoğlu E, Sezer S, Turhan T, Özgürtaş T. Evaluation
of atherogenic laboratory markers in Behçet’s disease patients with
vascular involvement. Arch Med Sci. 2019 Oct 27;16(3):531-537.
- Ruderman NB, Berger M. The formation of glutamine and alanine in
skeletal muscle. J Biol Chem 1974;249:5500
- Holecek M, Skopec F, Skalska H, Sprongl L. Effect of alanyl-glutamine
on leucine and protein metabolism in endotoxemic rats. JPEN
2000;24:215
- Smith RJ, Wilmore WW. Glutamine nutrition and requirements. JPEN 1990;
14(suppl):94
- de Oliveira Santos, R.; da Silva Cardoso, G.; da Costa Lima, L.; de
Sousa Cavalcante, M.L.; Silva, M.S.; Cavalcante, A.K.M.; Severo, J.S.;
de Melo Sousa, F.B.; Pacheco, G.; Alves, E.H.P.; et al. L-Glutamine
and Physical Exercise Prevent Intestinal Inflammation and Oxidative
Stress Without Improving Gastric Dysmotility in Rats with Ulcerative
Colitis. Inflammation 2021, 44, 617–632.
- Jia, C.J.; Dai, C.L.; Zhang, X.; Cui, K.; Xu, F.; Xu, Y.Q.
Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion
injury in rats. World J. Gastroenterol. 2006, 12, 1373–1378.
- Szijarto, A.; Hahn, O.; Batmunkh, E.; Stangl, R.; Kiss, A.; Lotz, G.;
Schaff, Z.; Vali, L.; Blazovics, A.; Gero, D.; et al. Short-term
alanyl-glutamine dipeptide pretreatment in liver ischemia-reperfusion
model: Effects on microcirculation and antioxidant status in rats.
Clin. Nutr. 2007, 26, 640–648.
- K. Takada, T. Nakane, K. Masuda, and H. Ishii, “Ursolic acid and
oleanolic acid, members of pentacyclic triterpenoid acids, suppress
TNF-𝛼-induced E-selectin expression by cultured umbilical vein
endothelial cells,” Phytomedicine, vol. 17, no. 14, pp. 1114–1119,
2010.
- K. Y. Kim, K. M. Lim, J. Y. Noh et al., “Novel antiplatelet activity
of protocatechuic acid through the inhibition of high shear
stress-induced platelet aggregation,” Journal of Pharmacology and
ExperimentalTherapeutics, vol. 343, no. 3, pp. 704–711, 2012
- Tang X, Liu J, Dong W, Li P, Li L, Lin C, Zheng Y, Hou J, Li D. The
cardioprotective effects of citric Acid and L-malic Acid on myocardial
ischemia/reperfusion injury. Evid Based Complement Alternat Med.
2013;2013:820695.
- Srinivasulu C, Ramgopal M, Ramanjaneyulu G, Anuradha CM, Suresh Kumar
C. Syringic acid (SA) ‒ A Review of Its Occurrence, Biosynthesis,
Pharmacological and Industrial Importance. Biomed Pharmacother. 2018
Dec;108:547-557.
- Cobb J, Eckhart A, Motsinger-Reif A, Carr B, Groop L, Ferrannini E.
α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired
Glucose Tolerance. Diabetes Care. 2016 Jun;39(6):988-95.
- Elbein AD, Pan YT, Pastuszak I, Carroll D: New insights on trehalose:
a multifunctional molecule. Glycobiology 2003, 13:17R–27R.
- Jain NK, Roy I: Effect of trehalose on protein structure. Protein Sci
2009, 18:24–36
- Sertoglu E, Omma A, Yucel C, Colak S, Sandıkcı SC, Ozgurtas T. The
relationship of serum VEGF and sVEGFR-1 levels with vascular
involvement in patients with Behçet’s disease. Scand J Clin Lab
Invest. 2018 Oct;78(6):443-449